EMEA-003040-PIP01-21
Key facts
| Active substance |
Izaflortaucipir (18F)
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0432/2021
|
| PIP number |
EMEA-003040-PIP01-21
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Life Molecular Imaging GmbH
Email: gra@life-mi.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|